Cystic fibrosis: a polymicrobial infectious disease

Area of Science:

• Medical Microbiology
• Pulmonology
• Genetics

Background:

• Cystic fibrosis (CF) is a lethal genetic disease, primarily affecting Caucasians.
• Chronic lower airway infections are central to CF pathophysiology, leading to lung damage and respiratory failure in most patients.
• Historically, CF infections were attributed to a limited number of bacterial species.

Purpose of the Study:

• To review evidence supporting the concept of polymicrobial infections in CF lungs.
• To discuss the significance of diverse bacterial communities in CF lung pathology.
• To explore the implications of understanding microbial dynamics for future therapeutic strategies.

Main Methods:

• Review of existing scientific literature.
• Analysis of molecular evidence for bacterial diversity in CF lungs.
• Discussion of host-pathogen-microbiome interactions.

Main Results:

• Molecular data indicate a diverse, polymicrobial community in CF lungs, challenging the traditional view of single-pathogen infections.
• The complex interplay of multiple microorganisms likely contributes significantly to lung pathology in CF.
• The concept of CF as an infectious disease with polymicrobial involvement is supported by current research.

Conclusions:

• CF lung infections are polymicrobial, involving a complex interplay of bacteria and the host immune system.
• Understanding these polymicrobial dynamics is crucial for developing effective therapeutic interventions.
• Future research should focus on the interactions within the CF lung microbiome to advance treatment outcomes.